Management of patients with seborrheic dermatitis
https://doi.org/10.33667/2078-5631-2021-27-56-60
Abstract
The article is of the overview nature and contains up-to-date information about the current methods of treatment of various forms of seborrheic dermatitis (SD). The data on modern methods of management of patients with severe forms of SD, allowing for a long time to achieve regression of skin rashes and significantly improve the quality of life of the patient, are presented.
About the Author
E. M. Markelova
Policlinic No. 5 of the Administrative Department of the President of Russia
Russian Federation
Russian Federation
Markelova Ekaterina M., dermatovenerologist, cosmetologist
Moscow
References
1. Borda LJ, Wikramanayake TC. Seborrheic Dermatitis and Dandruff: A Comprehensive Review. J Clin Investig Dermatol. 2015; 3 (2): 10.
2. Khramova. Seborrheic dermatitis of the scalp: from diagnosis to treatment: a textbook. ISMU of the Ministry of Health of Russia, Department of Dermatovenereology of the FPC and PPS. Irkutsk, 2016. 46 pages (in Russian).
3. Sébastien Menzinger, Emmanuel Laffitte.Dermiteséborrhéique: manifestations cliniques et priseen charge. RevMedSuisse 2011; volume 7. 752–758.
4. Jonas A. Adalsteinsson, Shivani Kaushik, Sonal Muzumdar, Emma Guttman-Yassky, Jonathan Ungar. An update on the microbiology, immunology and genetics of seborrheic dermatitis. Experimental Dermatology Volume 29, Issue 5 p. 481–489 03 March 2020.
5. Ro B.I., Dawson T.L. The role of sebaceous gland activity and scalp microflopal metabolism in the etiology of seborrheic dermatitis and dandruff. Investig. Dermatol. Symp. Proc. 2005. Vol. 10. P. 194–7.
6. Polonskaya A.S., Shatokhina E.A., Kruglova L.S. Seborrheic dermatitis: modern ideas about the etiology, pathogenesis and treatment approaches. Clinical Dermatology and Venereology. 2020; 19 (4): 451–458. https://doi.org/10.17116/ klinderma202019041451 (in Russian).
7. Wolf K., Goldsmith L.A., Katz S.I., Gilchrist B.A., Baller E. S., Leffel D. J. Fitzpatrick dermatology in clinical practice. In 3 vols. Volume 1, ch. 22. M.: Binom Publishing House. Knowledge Lab. 2012. pp. 235–242 (in Russian).
8. Dan Tucker, Sadia Masood. Seborrheic Dermatitis In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2020 Jan. 2020 Oct 3.
9. Pilgui E.I., Murashkin N.N. Clinical recommendations for the management of children with seborrheic dermatitis. Pediatricheskaia farmakologiia. 2015; 12 (5): 559–561. DOI: 10.15690/pf.v12i5.1458 (in Russian).
10. Monakhov S.A. New in the treatment of seborrheic dermatitis. Clinical Dermatology and Venereology. 2010. No. 1. P. 79–82 (in Russian).
11. Borda LJ, Perper M, Keri JE. Treatment of seborrheic dermatitis: a comprehensive review. J Dermatolog Treat. 2019; 30 (2): 158–169. https://doi.org/10.1080 /09546634.2018.1473554
12. Okokon EO, Verbeek JH, Ruotsalainen JH, Ojo OA, Bakhoya VN (2015) Topical antifungals for seborrheic dermatitis. Cochrane Database Syst Rev (4): 1–229.
13. L. S. Kruglova, D. V. Fedorov, A. G. Stenko, N. V. Gryazeva, A. B. Yakovlev. Current recommendations for the use of a multicomponent drug in dermatology. Medical alphabet. 2019. Vol. 2. No. 26 (401). pp. 67–72. https://doi. org/10.33667/2078–5631–2019–2–26(401)-67–72 (in Russian).
14. Schmidt-Rose T, Braren S, Folster H, Hillemann T, Oltrogge B, et al. (2011) Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff. Int J Cosmet Sci 33 (3): 276–282.
15. Panyukova S. V., Piruzyan A. L., Korsunskaya I. M. Seborrheic dermatitis: how to help a patient. Consilium Medicum. 2020; 22 (7): 46–48. DOI: 10.26442/20751753.2020.7.200314 (in Russian).
16. Schmidt-Rose T, et al. Efficacy of a Piroctone Olamine/climbazol Shampoo in Comparison with a Zinc Pyrithione Shampoo in Subjects with Moderate to Severe Dandruff. International Journal of Cosmetic Science. Vol. 33, No. 3, 2011, pp. 276–82.
17. Gadzhigoroeva A. G. New opportunities in the treatment of seborrheic dermatitis of the scalp. Clinical Dermatology and Venereology. 2005. No. 2. P. 70–72 (in Russian).
18. Goldust M, Rezaee E, Raghifar R, Hemayat S (2013) Treatment of seborrheic dermatitis: the efficiency of sertaconazole 2% cream vs tacrolimus 0.03% cream. Ann Parasitol 59 (2): 73–77.
19. Sugita T, Tajima M, Tsubuku H, Tsuboi R, Nishikawa A. A new calcineurin inhibitor, pimecrolimus, inhibits the growth of Malassezia spp. Antimicrob Agents Chemother. 2006; 50 (8): 2897–2898. https://doi.org/10.1128/ AAC.00687–06
20. Bolotnaya L. A. Capabilities of tacrolimus in the treatment of patients with chronic dermatoses. Ukrainian Journal of Dermatology, Venereology, Cosmetology. 2012; 2 (42): 27–32. (in Russian)
21. Ang-Tiu CU, Meghrajani CF Pimecrolimus 1% cream for the treatment of seborrheic dermatitis: a systematic review of randomized controlled trials. Expert Rev Clin Pharmacol. 2012. Vol. 5. No.1. P. 91–97.
22. Gupta AK, Richardson M, Paquet M. Systematic review of oral treatments for seborrheic dermatitis. J Eur Acad Dermatol Venereol. 2014; 28 (1): 16–26. https://doi.org/10.1111/jdv.12197
23. Ghodsi SZ, Abbas Z, Abedeni R. Efficacy of Oral Itraconazole in the Treatment and Relapse Prevention of Moderate to Severe Seborrheic Dermatitis: A Randomized, Placebo-Controlled Trial. Am J Clin Dermatol. 2015; 16 (5): 431–437. https://doi.org/10.1007/s40257–015–0133–9
24. Cömert A, Bekiroglu N, Gürbüz O, Ergun T. Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study. Am J Clin Dermatol. 2007; 8 (4): 235–238. https://doi.org/10.2165/00128071– 200708040–00005
25. Orfanos CE, Zouboulis CC. Oral retinoids in the treatment of seborrhoea and acne. Dermatology. 1998; 196 (1): 140–147. https://doi.org/10.1159/000017848
26. King K, Jones DH, Daltrey DC, Cunliffe WJ. A double-blind study of the effects of 13-cisretinoic acid on acne, sebum excretion rate and microbial population. BrJ Dermatol.1982; 107 (5): 583–90.
27. De Souza Leão Kamamoto C, Sanudo A, Hassun KM, Bagatin E. Low-dose oral isotretinoin for moderate to severe seborrhea and seborrheic dermatitis: a randomized comparative trial. Int J Dermatol. 2017; 56 (1): 80–85. https://doi. org/10.1111/ijd.13408
28. Kruglova L.S., Kotenko K.V., Korzhachkina N.B., Tubrovskaya S.N. Physiotherapy in dermatology. GEOTAR-Media. 304 pages.
29. Gambichler T, Breuckmann F, Boms S, Altmeyer P, Kreuter A. Narrowband UVB phototherapy in skin conditions beyond psoriasis. J Am Acad Dermatol. 2005; 52 (4): 660–670. https://doi.org/10.1016/j.jaad.2004.08.047
30. Dahl KB, Reymann F. Photochemotherapy in erythrodermic seborrhoic dermatitis. Arch Dermatol. 1977; 113 (9): 1295–6.
31. Davidovich M.I. Experience of using UVB311 nm in the treatment of seborrheic dermatitis. Regular issues of RMJ No. 9 from 20.05.2015 (in Russian).
32. Pirkhammer D, Seeber A, Honigsmann H, Tanew A. Narrow-band ultraviolet B (ATL 01) phototherapy is an effective and safe treatment option for patients with severe seborrheic dermatitis. Br J Dermatol. 2000; 143 (5): 964–8
33. Sigmundsdottir H., Johnston A., Gudjonsson J.E. et al. Narrowband-UVB irradiation decreases the production of pro-inflammatory cytokines by stimulated T cells. Arch. Dermatol. Res. 2005. Vol. 297, No. 1. P. 39–42
Review
For citations:
Markelova E.M. Management of patients with seborrheic dermatitis. Medical alphabet. 2021;(27):56-60. (In Russ.) https://doi.org/10.33667/2078-5631-2021-27-56-60
Views:
408
Email this article 